G. H. Whipple, A hitherto undescribed disease characterized anatomically by deposits of fat and fattyacids in the intestinal and mesentericlymphatic tissues, Bull. Johns Hopkins Hosp, vol.18, p.382, 1907.

J. H. Yardley and T. R. Hendrix, Combined electron and light microscopy in Whipple's disease. Demonstration of "bacillary bodies" in the intestine, Bull Johns Hopkins Hosp, vol.109, 1961.

T. Schneider, Whipple's disease: new aspects of pathogenesis and treatment, Lancet Infect Dis, vol.8, p.179, 2008.

X. , Whipple's arthritis. Joint, bone, spine : revue du rhumatisme, vol.83, 2016.

F. Fenollar, S. Laouira, H. Lepidi, J. M. Rolain, and D. Raoult, Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening, Clin Infect Dis, vol.47, 2008.

B. Desnues, K. Moussawi, and F. Fenollar, New insights into Whipple's disease and Tropheryma whipplei infections, Microbes Infect, vol.12, p.1102, 2010.

W. O. Dobbins, Whipple's disease, 1987.

T. Marth, D. Raoult, and . Whipple's-disease, Lancet, vol.361, p.239, 2003.

F. Fenollar, H. Lepidi, and D. Raoult, Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis, Clin Infect Dis, vol.33, p.1309, 2001.

J. G. Gubler, Whipple endocarditis without overt gastrointestinal disease: report of four cases, Ann Intern Med, vol.131, 1999.

D. V. Durand, C. Lecomte, P. Cathebras, H. Rousset, P. Godeau et al., Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne, Medicine (Baltimore), vol.76, 1997.

V. Touitou, Ocular Whipple's disease: therapeutic strategy and long-term follow-up, Ophthalmology, vol.119, p.1465, 2012.

R. L. Font, N. A. Rao, S. Issarescu, and W. J. Mcentee, Ocular involvement in Whipple's disease: light and electron microscopic observations, Arch Ophthalmol, vol.96, p.1431, 1978.

J. G. Williams, Ocular manifestations of Whipple disease: an atypical presentation, Arch Ophthalmol, vol.116, p.1232, 1998.

D. P. Symmons, A. N. Shepherd, P. L. Boardman, and P. A. Bacon, Pulmonary manifestations of Whipple's disease. The Quarterly journal of medicine, vol.56, 1985.

G. Urbanski, Whipple disease revealed by lung involvement: a case report and literature review, Chest, vol.141, p.1595, 2012.

C. A. Kelly, M. Egan, and J. Rawlinson, Whipple's disease presenting with lung involvement, Thorax, vol.51, p.343, 1996.

A. R. Marumganti and T. F. Murphy, Whipple's disease: neurological relapse presenting as headache for two years, Journal of general internal medicine, vol.23, p.2131, 2008.

R. A. Dolmans, C. H. Boel, M. M. Lacle, and J. G. Kusters, Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections, Clin Microbiol Rev, vol.30, 2017.

N. Bakkali, F. Fenollar, J. M. Rolain, and D. Raoult, Comment on: therapy for Whipple's disease, J Antimicrob Chemother, vol.61, p.968, 2008.

F. Fenollar, X. Puechal, and D. Raoult, Whipple's disease, N Engl J Med, vol.356, 2007.

F. Fenollar and D. Raoult, Infection: How should classic Whipple disease be managed?, Nat Rev Gastroenterol Hepatol, vol.7, p.246, 2010.

G. E. Feurle, V. Moos, T. Schneider, F. Fenollar, and D. Raoult, The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to Références 69. B. Desnues, D. Raoult, J. L. Mege, IL-16 is critical for Tropheryma whipplei replication in Whipple's disease, J Immunol, vol.175, 2005.

A. Elssner, A. I. Doseff, M. Duncan, M. Kotur, and M. D. Wewers, IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis, J Immunol, vol.172, 2004.

E. Ghigo, IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation, PLoS One, vol.5, p.13561, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02022462

T. Schneider, Treatment of refractory Whipple disease with interferon-gamma, Ann Intern Med, vol.129, 1998.

S. Genot, Murine model of infection by Tropheryma whipplei, Infect Immun, vol.74, 2006.

K. and A. Moussawi, Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei, PLoS Pathog, vol.6, p.1000722, 2010.

J. L. Casanova and L. Abel, Inborn errors of immunity to infection: the rule rather than the exception, J Exp Med, vol.202, 2005.

R. Levy, Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency, Proc Natl Acad Sci U S A, vol.113, p.8277, 2016.

A. Alcais, Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?, Ann N Y Acad Sci, 2010.

A. Alcais, L. Abel, and J. L. Casanova, Human genetics of infectious diseases: between proof of principle and paradigm, J Clin Invest, vol.119, p.2506, 2009.

J. Bustamante, S. Boisson-dupuis, L. Abel, and J. L. Casanova, Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFNgamma immunity, Semin Immunol, vol.26, p.454, 2014.

H. Bernuth, Pyogenic bacterial infections in humans with MyD88 deficiency, Science, vol.321, p.691, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01375224

C. Picard, Pyogenic bacterial infections in humans with IRAK-4 deficiency, Science, vol.299, p.2076, 2003.

S. Y. Zhang, L. Abel, and J. L. Casanova, Mendelian predisposition to herpes simplex encephalitis, Handbook of clinical neurology, vol.112, p.1091, 2013.

S. Okada, A. Puel, J. L. Casanova, and M. Kobayashi, Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity, Clinical & translational immunology, vol.5, p.114, 2016.

M. J. Ciancanelli, L. Abel, S. Y. Zhang, and J. L. Casanova, Host genetics of severe influenza: from mouse Mx1 to human IRF7, Curr Opin Immunol, vol.38, 2016.

J. L. Casanova and L. Abel, The human model: a genetic dissection of immunity to infection in natural conditions, Nat Rev Immunol, vol.4, 2004.

J. L. Casanova and L. Abel, Human genetics of infectious diseases: a unified theory, EMBO J, vol.26, 2007.

F. Biagi, -295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease, Eur J Clin Microbiol Infect Dis, vol.34, 1919.

K. M. Burkart, Association of asthma with a functional promoter polymorphism in the IL16 gene, J Allergy Clin Immunol, vol.117, 2006.

J. Glas, H. P. Torok, H. Unterhuber, M. Radlmayr, and C. Folwaczny, The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease, Clin Immunol, vol.106, 2003.

K. Reich, Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene, J Allergy Clin Immunol, vol.112, p.1191, 2003.

M. Martinetti, The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease, Gastroenterology, vol.136, p.2289, 2009.

G. E. Feurle, B. Dorken, E. Schopf, and V. Lenhard, HLA B27 and defects in the T-cell system in Whipple's disease, vol.9, p.385, 1979.

W. O. Dobbins, HLA antigens in Whipple's disease, Arthritis Rheum, vol.3, 1987.

J. C. Bai, Class I and class II HLA antigens in a homogeneous Argentinian population with Whipple's disease: lack of association with HLA-B 27, Am J Gastroenterol, vol.86, 1991.

I. Olivieri, Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease, The Journal of rheumatology, vol.28, 2001.

Y. Itan, The human gene damage index as a gene-level approach to prioritizing exome variants, Proc Natl Acad Sci U S A, vol.112, p.13615, 2015.

D. M. Rand and L. M. Kann, Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes from Drosophila, mice, and humans, Molecular biology and evolution, vol.13, 1996.

P. J. Cock, Biopython: freely available Python tools for computational molecular biology and bioinformatics, Bioinformatics, vol.25, p.1422, 2009.

N. Stoletzki and A. Eyre-walker, Estimation of the neutrality index, Molecular biology and evolution, vol.28, 2011.

K. E. Eilertson, J. G. Booth, and C. D. Bustamante, SnIPRE: selection inference using a Poisson random effects model, PLoS computational biology, vol.8, p.1002806, 2012.

M. Kircher, A general framework for estimating the relative pathogenicity of human genetic variants, Nat Genet, vol.46, p.310, 2014.

A. L. Shaffer, N. C. Emre, P. B. Romesser, and L. M. Staudt, IRF4: Immunity. Malignancy! Therapy? Clinical cancer research : an official journal of the American Association for, Cancer Research, vol.15, p.2954, 2009.

C. R. Escalante, Crystal structure of PU.1/IRF-4/DNA ternary complex, Mol Cell, vol.10, p.1097, 2002.

A. L. Brass, A. Q. Zhu, and H. Singh, Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers, EMBO J, vol.18, p.977, 1999.

M. Lohoff and T. W. Mak, Roles of interferon-regulatory factors in T-helper-cell differentiation, Nat Rev Immunol, vol.5, 2005.

J. F. Lau, J. P. Parisien, and C. M. Horvath, Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors, Proc Natl Acad Sci U S A, vol.97, 2000.

M. Huber and M. Lohoff, IRF4 at the crossroads of effector T-cell fate decision, Eur J Immunol, vol.44, p.1886, 2014.

S. Gupta, M. Jiang, A. Anthony, and A. B. Pernis, Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4, J Exp Med, vol.190, p.1837, 1999.

K. Honma, Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS, Proc Natl Acad Sci U S A, vol.102, p.16001, 2005.

C. E. Chartouni, L. Schwarzfischer, and M. Rehli, Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming, Immunobiology, vol.215, 2010.

C. M. Hu, S. Y. Jang, J. C. Fanzo, and A. B. Pernis, Modulation of T cell cytokine production by interferon regulatory factor-4, J Biol Chem, vol.277, 2002.

J. Rengarajan, Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression, J Exp Med, vol.195, p.1003, 2002.

M. Saito, A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma, Cancer cell, vol.12, 2007.

Y. Zheng, Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses, Nature, vol.458, p.351, 2009.

J. M. Pongubala, PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity, Molecular and cellular biology, vol.12, 1992.

. Références,

V. Shukla and R. Lu, IRF4 and IRF8: Governing the virtues of B Lymphocytes, Frontiers in biology, vol.9, 2014.

J. W. Williams, Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation, Nature communications, vol.4, p.2990, 2013.

F. Qian, The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation, Journal of molecular cell biology, vol.7, p.557, 2015.

R. Tussiwand, Compensatory dendritic cell development mediated by BATF-IRF interactions, Nature, vol.490, 2012.

P. Li, BATF-JUN is critical for IRF4-mediated transcription in T cells, Nature, vol.490, 2012.

E. Glasmacher, A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes, Science, vol.338, p.975, 2012.

K. Ochiai, Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4, Immunity, vol.38, 2013.

M. Lohoff, Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4, Proc Natl Acad Sci U S A, vol.99, p.11808, 2002.

N. Tominaga, Development of Th1 and not Th2 immune responses in mice lacking IFNregulatory factor-4, International immunology, vol.15, 2003.

D. Sacks and N. Noben-trauth, The immunology of susceptibility and resistance to Leishmania major in mice, Nat Rev Immunol, vol.2, p.845, 2002.

M. Lohoff, Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells, J Exp Med, vol.200, 2004.

K. Honma, Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells, Proc Natl Acad Sci U S A, vol.105, p.15890, 2008.

R. Jabeen, Th9 cell development requires a BATF-regulated transcriptional network, J Clin Invest, vol.123, p.4641, 2013.

B. C. Betz, Batf coordinates multiple aspects of B and T cell function required for normal antibody responses, J Exp Med, vol.207, p.933, 2010.

V. Staudt, Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells, Immunity, vol.33, 2010.

H. C. Chang, The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation, Nat Immunol, vol.11, 2010.

T. Tamiya, Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction, J Immunol, vol.191, p.2360, 2013.

J. Mudter, The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6, J Clin Invest, vol.118, p.2415, 2008.

A. Brustle, The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4, Nat Immunol, vol.8, p.958, 2007.

C. Yang, D. He, C. Yin, and J. Tan, Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis, Scandinavian journal of immunology, vol.82, 2015.

E. S. Hwang, Transcriptional regulation of T helper 17 cell differentiation, Yonsei medical journal, vol.51, 2010.

M. Ciofani, A validated regulatory network for Th17 cell specification, Cell, vol.151, p.289, 2012.

L. Durant, Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis, Immunity, vol.32, p.605, 2010.

X. Ouyang, Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation, Nature communications, vol.2, p.314, 2011.

J. Mudter, IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo, Inflammatory bowel diseases, vol.17, p.1343, 2011.

. Références,

E. Cretney, A. Kallies, and S. L. Nutt, Differentiation and function of Foxp3(+) effector regulatory T cells, Trends Immunol, vol.34, 2013.

A. Chaudhry, CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner, vol.326, p.986, 2009.

R. Nayar, TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation, Proc Natl Acad Sci U S A, vol.109, p.2794, 2012.

M. Huber, IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis, J Clin Invest, vol.123, p.247, 2013.

K. Man, The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells, Nat Immunol, vol.14, p.1155, 2013.

F. Raczkowski, The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells, Proc Natl Acad Sci U S A, vol.110, p.15019, 2013.

S. Yao, Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation, Immunity, vol.39, p.833, 2013.

R. Nayar, Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection, J Immunol, vol.192, 2014.

S. Ma, S. Pathak, L. Trinh, and R. Lu, Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development, Blood, vol.111, p.1396, 2008.

S. Pathak, S. Ma, L. Trinh, and R. Lu, A role for interferon regulatory factor 4 in receptor editing, Molecular and cellular biology, vol.28, p.2815, 2008.

U. Klein, Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination, Nat Immunol, vol.7, p.773, 2006.

C. Tunyaplin, Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation, J Immunol, vol.173, p.1158, 2004.

T. Tamura, IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity, J Immunol, vol.174, p.2573, 2005.

B. Vander-lugt, Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation, Nat Immunol, vol.15, p.161, 2014.

S. Bajana, K. Roach, S. Turner, J. Paul, and S. Kovats, IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation, J Immunol, vol.189, 2012.

E. K. Persson, IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation, Immunity, vol.38, p.958, 2013.

A. Schlitzer, IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses, Immunity, vol.38, p.970, 2013.

Y. Gao, Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells, Immunity, vol.39, 2013.

C. G. Briseno, Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells, Cell reports, vol.15, p.2462, 2016.

M. Merad, P. Sathe, J. Helft, J. Miller, and A. Mortha, The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting, Annu Rev Immunol, vol.31, p.563, 2013.

A. Lehtonen, Differential expression of IFN regulatory factor 4 gene in human monocytederived dendritic cells and macrophages, J Immunol, vol.175, 2005.

M. Yamamoto, Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development, PLoS One, vol.6, p.25812, 2011.

A. M. Becker, IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors, Blood, vol.119, 2003.

. Références,

S. Nam, Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function, J Leukoc Biol, vol.100, p.1273, 2016.

D. O. Adams and T. A. Hamilton, The cell biology of macrophage activation, Annu Rev Immunol, vol.2, p.283, 1984.

M. Stein, S. Keshav, N. Harris, and S. Gordon, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, vol.176, 1992.

C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill, M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, vol.164, p.6166, 2000.

M. Egawa, Inflammatory monocytes recruited to allergic skin acquire an antiinflammatory M2 phenotype via basophil-derived interleukin-4, Immunity, vol.38, 2013.

L. Arnold, Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis, J Exp Med, vol.204, p.1057, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00136917

M. Nahrendorf and F. K. Swirski, Monocyte and macrophage heterogeneity in the heart, Circulation research, vol.112, p.1624, 2013.

J. Xue, Transcriptome-based network analysis reveals a spectrum model of human macrophage activation, Immunity, vol.40, 2014.

Y. Lavin, Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment, Cell, vol.159, p.1312, 2014.

P. J. Murray, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, vol.41, 2014.

K. Schroder, Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages, Proc Natl Acad Sci U S A, vol.109, p.944, 2012.

F. O. Martinez, Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences, Blood, vol.121, p.57, 2013.

T. Shay, Conservation and divergence in the transcriptional programs of the human and mouse immune systems, Proc Natl Acad Sci U S A, vol.110, p.2946, 2013.

T. Satoh, The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection, Nat Immunol, vol.11, 2010.

A. Achuthan, Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation, J Clin Invest, vol.126, 2016.

W. Zhu, Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype, International immunopharmacology, vol.35, 2016.

H. Negishi, Negative regulation of Toll-like-receptor signaling by IRF-4, Proc Natl Acad Sci U S A, vol.102, p.15989, 2005.

M. J. Ciancanelli, Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency, Science, vol.348, 2015.

S. Hambleton, IRF8 mutations and human dendritic-cell immunodeficiency, N Engl J Med, vol.365, 2011.

S. Salem, Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation, Blood, vol.124, p.1894, 2014.

E. M. Mace, Biallelic mutations in IRF8 impair human NK cell maturation and function, J Clin Invest, vol.127, 2017.

L. L. Andersen, Functional IRF3 deficiency in a patient with herpes simplex encephalitis, J Exp Med, vol.212, p.1371, 2015.

F. Rieux-laucat and J. L. Casanova, Immunology. Autoimmunity by haploinsufficiency. Science, vol.345, p.1560, 2014.

B. Afzali, BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency, Nat Immunol, vol.18, 2017.

. Références,

R. Perez-de and D. , Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis, Immunity, vol.33, p.400, 2010.

G. D. Kalliolias and L. B. Ivashkiv, IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38, J Immunol, vol.180, 2008.

J. B. Vandeusen, STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo, Eur J Immunol, vol.36, issue.623, 2006.

Y. C. Liu, X. B. Zou, Y. F. Chai, and Y. M. Yao, Macrophage polarization in inflammatory diseases, International journal of biological sciences, vol.10, p.520, 2014.

S. Tamoutounour, Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin, Immunity, vol.39, p.925, 2013.

S. Epelman, Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation, Immunity, vol.40, p.91, 2014.

C. C. Bain, Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice, Nat Immunol, vol.15, p.929, 2014.

G. Vogt and C. Nathan, In vitro differentiation of human macrophages with enhanced antimycobacterial activity, J Clin Invest, vol.121, 2011.

J. Bustamante, Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease, Nat Immunol, vol.12, 2011.

G. Noel, A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions, Scientific reports, vol.7, p.45270, 2017.

F. Conti, . Md, . Phd, O. Saul, . Lugo-reyes et al.,

M. Hubeau, N. Phd, M. D. Karaca, and F. Maylis-de-suremain, Antoine Gu erin

L. A. Baba, C. Phd, . Prando, . Md, G. G. Phd et al.,

S. Espinosa, . Md, . Phd, . Barlan, . Md et al.,

A. Bondarenko, . Md, M. D. Bb-liudmyla-chernyshova, and P. Ciznar,

A. Diabate, . As, A. S. St-ephanie-ndaga, A. S. Barik-konte, A. Czarna et al.,

J. Casanova, . Md, J. Phd, and . Bustamante,

I. Rome, T. City, and M. Merida,

P. S~-ao, . Curitiba, M. Brazil;-casablanca, B. Plata, . Aires et al.,

A. Dhabi,

U. ;. Kiev, S. Bratislava, N. Y. York, and I. Tehran, Other infections Fifty-four (76%) patients had other bacterial and fungal infections caused by common microorganisms affecting children with CGD. The organisms most frequently isolated were Staphylococcus, Aspergillus, and Salmonella species, followed by Candida

, Fifty-eight (82%) patients are still alive, and their most recent

M. C. Dinauer and S. H. Orkin, Chronic granulomatous disease, Annu Rev Med, vol.43, pp.117-141, 1992.


S. M. Holland, Chronic granulomatous disease, Hematol Oncol Clin North Am, vol.27, pp.89-99, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00809510

B. H. Segal, T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland, Genetic, biochemical, and clinical features of chronic granulomatous disease, Medicine (Baltimore), vol.79, pp.170-200, 2000.

E. B. De-oliveira-junior, J. Bustamante, P. E. Newburger, and A. Condino-neto, The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes, Scand J Immunol, vol.73, pp.420-427, 2011.

D. Roos, D. B. Kuhns, M. A. Bustamante, J. Kannengiesser, C. De-boer et al., Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update), Blood Cells Mol Dis, vol.44, pp.291-300, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00809521

D. Roos, D. B. Kuhns, M. A. Roesler, J. Lopez, J. A. Ariga et al., Hematologically important mutations: X-linked chronic granulomatous disease (third update), Blood Cells Mol Dis, vol.45, pp.246-65, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00809510

E. B. De-oliveira-junior, C. Prando, J. A. Lopez, J. C. Arango, M. Buzolin et al., High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in X-linked chronic granulomatous disease

, Scand J Immunol, vol.76, pp.158-66, 2012.

J. A. Winkelstein, M. C. Marino, R. B. Johnston, J. Boyle, J. Curnutte et al., Report on a national registry of 368 patients, Medicine (Baltimore), vol.79, pp.155-69, 2000.

B. E. Marciano, C. Spalding, A. Fitzgerald, D. Mann, T. Brown et al., Common severe infections in chronic granulomatous disease, Clin Infect Dis, vol.60, pp.1176-83, 2015.

N. Jabado, J. L. Casanova, E. Haddad, F. Dulieu, J. C. Fournet et al., Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease, Clin Infect Dis, vol.27, pp.1437-1478, 1998.

A. Zwerling, M. A. Behr, A. Verma, T. F. Brewer, D. Menzies et al., The BCG World Atlas: a database of global BCG vaccination policies and practices, PLoS Med, vol.8, p.1001012, 2011.

C. Deffert, M. G. Schappi, J. C. Pache, J. Cachat, D. Vesin et al., Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation, PLoS Pathog, vol.10, p.1004325, 2014.

J. Bustamante, G. Aksu, G. Vogt, L. De-beaucoudrey, F. Genel et al., BCG-osis and tuberculosis in a child with chronic granulomatous disease, J Allergy Clin Immunol, vol.120, pp.32-40, 2007.

M. Y. Koker, Y. Camcioglu, K. Van-leeuwen, S. S. Kilic, I. Barlan et al., Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients, J Allergy Clin Immunol, vol.132, pp.1156-63, 2013.

P. P. Lee, K. W. Chan, L. Jiang, T. Chen, C. Li et al., Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis, Pediatr Infect Dis J, vol.27, pp.224-254, 2008.

C. J. Lin, S. C. Wang, C. L. Ku, J. K. Kao, M. Chen et al., Successful unrelated cord blood stem cell transplantation in an X-linked chronic granulomatous disease patient with disseminated BCG-induced infection, Pediatr Neonatol, vol.56, pp.346-50, 2015.

R. Naidoo, N. Jordaan, K. W. Chan, L. Roux, D. M. Pienaar et al., A novel CYBB mutation with the first genetically confirmed case of chronic granulomatous disease in South Africa, S Afr Med J, vol.101, pp.768-777, 2011.

G. Khotaei, A. Hirbod-mobarakeh, D. Amirkashani, F. Manafi, and N. Rezaei, Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease, Braz J Infect Dis, vol.16, pp.491-493, 2012.

L. A. Baba, F. Ailal, E. Hafidi, N. Hubeau, M. Jabot-hanin et al., Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds, J Clin Immunol, vol.34, pp.452-460, 2014.

S. O. Lugo-reyes, F. Suarez, R. M. Herbigneaux, H. Pacquement, Y. Reguerre et al., Hodgkin lymphoma in 2 children with chronic granulomatous disease, J Allergy Clin Immunol, vol.127, pp.1-3, 2011.

J. X. He, S. Y. Zhao, and Z. F. Jiang,

, Zhongguo Dang Dai Er Ke Za Zhi, vol.12, pp.490-493, 2010.

R. El-kares, M. R. Barbouche, H. Elloumi-zghal, M. Bejaoui, J. Chemli et al., Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia, J Hum Genet, vol.51, pp.887-95, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-01375263

M. Gentsch, A. Kaczmarczyk, K. Van-leeuwen, M. De-boer, M. Kaus-drobek et al., Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD), Hum Mutat, vol.31, pp.151-159, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00820713

C. Barese, S. Copelli, R. Zandomeni, M. Oleastro, M. Zelazko et al., X-linked chronic granulomatous disease: first report of mutations in patients of Argentina, J Pediatr Hematol Oncol, vol.26, pp.656-60, 2004.

D. M. Allen and H. H. Chng, Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease, J Infect, vol.26, pp.83-89, 1993.

E. G. Carnide, C. A. Jacob, A. M. Castro, and A. C. Pastorino, Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients, Pediatr Allergy Immunol, vol.16, pp.5-9, 2005.

M. J. Chusid, J. E. Parrillo, and A. S. Fauci, Diagnosis in a 27-year-old man with Mycobacterium fortuitum, JAMA, vol.233, pp.1295-1301, 1975.

D. Mansoory, N. A. Roozbahany, H. Mazinany, and A. Samimagam, Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease, Clin Infect Dis, vol.37, pp.107-115, 2003.

R. Mouy, A. Fischer, E. Vilmer, R. Seger, and C. Griscelli, Incidence, severity, and prevention of infections in chronic granulomatous disease, J Pediatr, vol.114, pp.555-60, 1989.

H. B. Oh, J. S. Park, W. Lee, S. J. Yoo, J. H. Yang et al., Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients, J Korean Med Sci, vol.19, pp.218-240, 2004.

S. Ohga, K. Ikeuchi, R. Kadoya, K. Okada, C. Miyazaki et al., Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease, J Infect, vol.34, pp.147-50, 1997.

R. S. Weening, D. Boer, M. Kuijpers, T. W. Neefjes, V. M. Hack et al., Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease, Clin Exp Immunol, vol.122, pp.410-417, 2000.

H. Salvator, N. Mahlaoui, E. Catherinot, E. Rivaud, B. Pilmis et al., Pulmonary manifestations in adult patients with chronic granulomatous disease, Eur Respir J, vol.45, pp.1613-1636, 2015.

H. Z. Elloumi and S. M. Holland, Diagnostic assays for chronic granulomatous disease and other neutrophil disorders, Methods Mol Biol, vol.412, pp.505-528, 2007.

J. L. Casanova, E. Jouanguy, S. Lamhamedi, S. Blanche, and A. Fischer, Immunological conditions of children with BCG disseminated infection, Lancet, vol.346, p.581, 1995.

E. A. Talbot, M. D. Perkins, S. F. Silva, and R. Frothingham, Disseminated Bacille Calmette-Guerin disease after vaccination: case report and review, Clin Infect Dis, vol.24, pp.1139-1185, 1997.

S. M. Graham, T. Ahmed, F. Amanullah, R. Browning, V. Cardenas et al., Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel, J Infect Dis, vol.205, issue.2, pp.199-208, 2012.

J. Feinberg, C. Fieschi, R. Doffinger, M. Feinberg, T. Leclerc et al., Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4-and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes, Eur J Immunol, vol.34, pp.3276-84, 2004.

E. B. De-oliveira-junior, N. B. Zurro, C. Prando, O. Cabral-marques, P. V. Pereira et al., Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: first report from the LASID registry, Pediatr Blood Cancer, vol.62, pp.2101-2108, 2015.

J. Bustamante, C. Picard, C. Fieschi, F. , O. Feinberg et al., A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease, J Med Genet, vol.44, p.65, 2007.

J. Bustamante, A. A. Arias, G. Vogt, C. Picard, L. B. Galicia et al., Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease, Nat Immunol, vol.12, pp.213-234, 2011.

F. Conti, C. Aragao-filho, W. Prando, C. Deswarte, C. Hubeau et al., Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-gammaR1 or IFN-gammaR2 deficiency, J Allergy Clin Immunol, vol.135, pp.1393-1398, 2015.

C. Deffert, J. Cachat, and K. H. Krause, Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections, Cell Microbiol, vol.16, pp.1168-78, 2014.

F. Fattahi, M. Badalzadeh, L. Sedighipour, M. Movahedi, M. R. Fazlollahi et al., Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease, J Clin Immunol, vol.31, pp.792-801, 2011.

J. M. Van-den-berg, E. Van-koppen, A. Ahlin, B. H. Belohradsky, E. Bernatowska et al., Chronic granulomatous disease: the European experience, PLoS One, vol.4, p.5234, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00382226

S. Boisson-dupuis, J. Bustamante, J. El-baghdadi, Y. Camcioglu, N. Parvaneh et al., Inherited and acquired immunodeficiencies underlying tuberculosis in childhood, Immunol Rev, vol.264, pp.103-123, 2015.

S. Boisson-dupuis, E. Baghdadi, J. Parvaneh, N. Bousfiha, A. Bustamante et al., IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, PLoS One, vol.6, p.18524, 2011.

L. De-beaucoudrey, A. Samarina, J. Bustamante, A. Cobat, S. Boisson-dupuis et al., Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries, Medicine (Baltimore), vol.89, pp.381-402, 2010.

, J ALLERGY CLIN IMMUNOL, vol.138, issue.1

L. B. Adams, M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl, Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice, Tuber Lung Dis, vol.78, pp.237-283, 1997.

M. Fujita, E. Harada, T. Matsumoto, Y. Mizuta, S. Ikegame et al., Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease, Clin Exp Immunol, vol.160, pp.457-60, 2010.

C. S. Yang, J. M. Yuk, and E. K. Jo, The role of nitric oxide in mycobacterial infections, Immune Netw, vol.9, pp.46-52, 2009.

B. E. Marciano, C. Y. Huang, G. Joshi, N. Rezaei, B. C. Carvalho et al., BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies, J Allergy Clin Immunol, vol.133, pp.1134-1175, 2014.